AU2002226074A1 - E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof - Google Patents
E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereofInfo
- Publication number
- AU2002226074A1 AU2002226074A1 AU2002226074A AU2607402A AU2002226074A1 AU 2002226074 A1 AU2002226074 A1 AU 2002226074A1 AU 2002226074 A AU2002226074 A AU 2002226074A AU 2607402 A AU2607402 A AU 2607402A AU 2002226074 A1 AU2002226074 A1 AU 2002226074A1
- Authority
- AU
- Australia
- Prior art keywords
- stce
- coli
- binding protein
- esterase inhibitor
- esterase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000014914 Carrier Proteins Human genes 0.000 title 1
- 241001646719 Escherichia coli O157:H7 Species 0.000 title 1
- 108091008324 binding proteins Proteins 0.000 title 1
- 229940009550 c1 esterase inhibitor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24367500P | 2000-10-26 | 2000-10-26 | |
| US60/243,675 | 2000-10-26 | ||
| PCT/US2001/047719 WO2002034918A2 (en) | 2000-10-26 | 2001-10-26 | E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002226074A1 true AU2002226074A1 (en) | 2002-05-06 |
Family
ID=22919663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002226074A Abandoned AU2002226074A1 (en) | 2000-10-26 | 2001-10-26 | E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US6872559B2 (en) |
| AU (1) | AU2002226074A1 (en) |
| WO (1) | WO2002034918A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7264922B2 (en) * | 2000-10-26 | 2007-09-04 | Wisconsin Alumni Research Foundation | Method of reducing complement - mediated disruption of cells |
| US7214479B2 (en) * | 2000-10-26 | 2007-05-08 | Wisconsin Alumni Research Foundation | E. coli O157:H7 C1-INH-binding protein and methods of use |
| WO2013172954A1 (en) * | 2012-05-17 | 2013-11-21 | Ra Pharmaceuticals, Inc | Peptide and peptidomimetic inhibitors |
| WO2014186622A2 (en) * | 2013-05-15 | 2014-11-20 | Annexon, Inc. | Methods of treatment for guillain-barre syndrome |
| SG11201510316UA (en) | 2013-07-09 | 2016-01-28 | Annexon Inc | Anti-complement factor c1q antibodies and uses thereof |
| PL3215527T3 (en) | 2014-11-05 | 2025-04-28 | Annexon, Inc. | Humanized anti-complement factor c1q antibodies and uses thereof |
| AU2016361517C1 (en) | 2015-11-24 | 2024-06-06 | Annexon, Inc. | Anti-complement factor C1q Fab fragments and uses thereof |
| US12486322B2 (en) | 2021-12-13 | 2025-12-02 | Annexon, Inc. | Anti-complement factor C1q antibodies with single binding arms and uses thereof |
-
2001
- 2001-10-26 WO PCT/US2001/047719 patent/WO2002034918A2/en not_active Ceased
- 2001-10-26 US US10/002,309 patent/US6872559B2/en not_active Expired - Fee Related
- 2001-10-26 AU AU2002226074A patent/AU2002226074A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6872559B2 (en) | 2005-03-29 |
| WO2002034918A2 (en) | 2002-05-02 |
| WO2002034918A3 (en) | 2003-01-30 |
| US20020160433A1 (en) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001271744A1 (en) | Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 | |
| AUPR688101A0 (en) | Protein domains and their ligands | |
| AU6058500A (en) | Fusion protein and uses thereof | |
| AU5340399A (en) | Proteases and associated proteins | |
| AU2002226074A1 (en) | E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof | |
| AU1479400A (en) | Milk protein dispersions | |
| AU2001274566A1 (en) | Novel protein and dna thereof | |
| AU2533299A (en) | Microbial assay | |
| AU2001237592A1 (en) | Enzymes and uses relating thereto | |
| AU5196699A (en) | Novel gene and protein pgth encoded thereby | |
| AU3955099A (en) | Novel gene and protein encoded thereby | |
| AU2001241880A1 (en) | 2504, 15977, and 14760, novel protein kinase family members and uses therefor | |
| AU3411999A (en) | Novel rnase-like protein and its use | |
| AU5672999A (en) | Maize repair protein orthologue-1 and uses thereof | |
| AU5034200A (en) | Oxidoreductase proteins | |
| AU2002239235A1 (en) | Gpcr-like protein and nucleic acids encoding same | |
| AU2001250047A1 (en) | Effector-specific protein assembly and uses thereof | |
| AU2001274563A1 (en) | Novel polypeptide and its dna | |
| AU2001234150A1 (en) | Novel protein and gene encoding the same | |
| AU5196799A (en) | Novel gene and protein osbh encoded thereby | |
| AU2001282259A1 (en) | Nucleic acids and pathogenic e.coli proteins, and their uses | |
| AU2001278777A1 (en) | Irap-binding protein | |
| AU1999300A (en) | An e. coli protein tyrosine kinase and its uses | |
| AU2001230560A1 (en) | Novel gene tig104alpha and protein tig104alpha encoded thereby | |
| AU2001273447A1 (en) | Tetraspan protein and uses thereof |